Research output per year
Research output per year
- 12 results
Search results
-
2021
Efficacy of tumour-necrosis factor-inhibitor in moderate disease activity rheumatoid arthritis: sub-analysis of the ‘VEDERA’ trial
Shukla, R., Emery, P. & Buch, M., 8 Oct 2021, (Accepted/In press) In: Rheumatology.Research output: Contribution to journal › Letter › peer-review
-
2019
Abnormal electrophysiological testing associates with future incidental significant arrhythmia in scleroderma
Bissell, L-A., Dumitru, R. B., Erhayiem, B., Abignano, G., Fent, G., Kidambi, A., Donica, H., Burska, A. N., Galdo, F. D., Biglands, J., Greenwood, J. P., Plein, S., Graham, L. & Buch, M. H., 3 Oct 2019, In: Rheumatology (Oxford, England).Research output: Contribution to journal › Letter › peer-review
-
First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis
Fent, G., Mankia, K., Erhayiem, B., Hunt, L., Nam, J. L., Bissell, L-A., Foley, J. R., Chew, P. G., Brown, L. E., Greenwood, J. P., Emery, P., Plein, S. & Buch, M. H., Aug 2019, In: Annals of the rheumatic diseases. 78, 8, p. 1138-1140 3 p.Research output: Contribution to journal › Letter › peer-review
-
Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis
Mortimer, I., Bissell, L-A., Hensor, E. M. A., Kozera, L., Mackie, S. L., Burska, A. N., Nam, J. L., Keen, H., Villeneuve, E., Donica, H., Buch, M. H., Conaghan, P. G., Emery, P., Morgan, A. W. & Andrews, J., 1 Sept 2019, In: Rheumatology (Oxford, England). 58, 9, p. 1684-1686 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Response to: 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Humby et al
Buch, M. H., Melville, A. & McGonagle, D. G., 13 Jul 2019, (E-pub ahead of print) In: Annals of the rheumatic diseases.Research output: Contribution to journal › Letter › peer-review
-
Response to 'Correspondence to viewpoint 'Defining refractory rheumatoid arthritis' by Buch' by Roodenrijs et al
Buch, M. H., Oct 2019, In: Annals of the rheumatic diseases. 78, 10, p. e106Research output: Contribution to journal › Letter › peer-review
-
2016
Does high-dose extended course cyclophosphamide and methylprednisolone pulse therapy have a role in the management of systemic sclerosis-related interstitial lung disease?
Abignano, G., Bissell, L-A., Emery, P., Del Galdo, F. & Buch, M. H., Dec 2016, In: Rheumatology (Oxford, England). 55, 12, p. 2273-2275 3 p.Research output: Contribution to journal › Letter › peer-review
-
2014
Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort: A Mendelian randomisation approach
Yarwood, A., Viatte, S., Plant, D., Morgan, A. W., Isaacs, J., Wilson, A. G., Hyrich, K., Eyre, S., Barton, A. & Buch, M., 2014, In: Annals of the rheumatic diseases. 73, 5, p. 938-940 2 p.Research output: Contribution to journal › Letter › peer-review
-
2013
Statins do not influence clinical response and B cell depletion after rituximab treatment in rheumatoid arthritis
Das, S., Fernandez Matilla, M., Dass, S., Buch, M. H., Rawstron, A. C., Vital, E. M. & Emery, P., Mar 2013, In: Annals of the rheumatic diseases. 72, 3, p. 463-4 2 p.Research output: Contribution to journal › Letter › peer-review
-
2010
Symmetrical polyarthritis. Time for treatment targets in rheumatoid arthritis
Treat to Target UK Steering Group, 4 Aug 2010, In: BMJ (Clinical Research Edition). 341, p. c4170Research output: Contribution to journal › Letter › peer-review
-
2009
Long-term efficacy and toxicity of ciclosporin A in combination with methotrexate in poor prognosis rheumatoid arthritis
Bejarano, V., Conaghan, P. G., Proudman, S. M., Buch, M. H., Brown, A. K. & Emery, P., May 2009, In: Annals of the rheumatic diseases. 68, 5, p. 761-3 3 p.Research output: Contribution to journal › Letter › peer-review
-
Re-treatment of rheumatoid arthritis patients who were initial nonresponders to rituximab: comment on the article by Thurlings et al
Vital, E. M., Dass, S., Buch, M. H., Rawstron, A. C., Ponchel, F., McGonagle, D. & Emery, P., Jun 2009, In: Arthritis and Rheumatism. 60, 6, p. 1867 1 p.Research output: Contribution to journal › Letter › peer-review